QXO

Cardiovascular Machine Learning-Based Notification Software

产品代码
QXO
器械名称
Cardiovascular Machine Learning-Based Notification Software
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 870.2380
FDA 专业组
Cardiovascular
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
2 件

FDA 分类定义

Cardiovascular machine learning-based notification software employs machine learning techniques to suggest the likelihood of a cardiovascular disease or condition for further referral or diagnostic follow-up. The software identifies a single condition based on one or more non-invasive physiological inputs as part of routine medical care. It is intended as the basis for further testing and is not intended to provide diagnostic quality output. It is not intended to identify or detect arrhythmias.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(1 件)

数据窗口为最近三年。最新一件:2026-06-08。

510(k) 号批准日期申请人器械名称摘要
K2603322026-06-08Pathwai, Inc.EchoNextPDF

其中 1 件的 Summary 已存档在本站,点 PDF 直接下载;其余给 FDA 官方链接。

FDA 官方分类页: QXO
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。